drugset
drugset / Trial / NCT02168205

Food Effect and CYP1A2 Induction Study in Healthy Subjects

NCT02168205 ↗

Phase 1 Completed 55 enrolled Celgene Corporation
RandomizedCrossoverOpen-labelOther

Summary

This study will evaluate the effect of food and smoking on healthy older subjects taking pomalidomide.

Timeline

Start
2014-05-30
Primary completion
2014-09-19
Completion
2014-09-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Pomalidomide Other / unclassified 4 mg Oral

Indications

No indication recorded.